Virus May Be Linked To Obesity -- Early Findings Hint At Relationship

April 08, 1997

A virus that can cause obesity in animals may be linked to some cases of obesity in humans, researchers at the University of Wisconsin Medical School have found.

A preliminary study of 199 people has shown that as many as 15 percent of obese people may carry antibodies to the virus, indirect evidence that they once were exposed to the virus itself. None of the lean volunteers tested had the antibodies.

Dr. Nikhil Dhurandhar described the findings Mon., April 7, at the Experimental Biology annual meeting in New Orleans. An assistant research scientist in the UW Medical School department of medicine, Dhurandhar conducted the research with UW Medical School Professor of Medicine and Nutritional Sciences Dr. Richard Atkinson.

Between 80 and 90 million Americans are obese, defined as having a body-mass index of 27 or above. Body mass index is calculated by dividing a person's weight in kilograms by the square of height in meters. A viral connection to obesity in humans has never been seriously considered before, the researchers noted.

Dhurandhar first found that one type of adenovirus that infects birds and is found only in his native India could induce obesity when it was injected into chickens.

Human adenoviruses form a large family of some 50 viruses. Transmitted through the air, they can cause upper respiratory infections, cold symptoms, gastrointestinal problems and eye inflammation in humans.

Dhurandhar and Atkinson next injected laboratory animals with a form of adenovirus known to affect humans, Ad-36, which resulted in obesity.

"A paradoxical characteristic of the virus is that in animals it appears to produce low levels of cholesterol and triglycerides along with the obesity," said Dhurandhar, noting that obesity is usually accompanied by elevated levels of these substances.

In the current study, Dhurandhar tested 154 obese and 45 lean human volunteers for the presence of antibodies to Ad-36. He found about 15 percent of the obese volunteers had antibodies to Ad-36 while the lean volunteers showed none.

The antibody-positive obese people had significantly lower cholesterol and triglycerides levels than the antibody-negative obese people, a pattern similar to that seen in animals infected with Ad-36. But the two groups did not differ on any of 29 other measures the researchers compared, including age or family history of obesity.

In males the presence of antibodies was associated with a significantly better response to treatment with obesity drugs, said Dhurandhar.

"There has been an alarming worldwide increase in the prevalence of obesity in the past 30 years," said Atkinson, noting that its prevalence in the United States rose 30 percent between 1980 and 1990, affecting more than 33 percent of the population. "This increase is the type of pattern that might occur with a new infectious disease, as has been seen with the AIDS virus. A great deal of further research is necessary to determine if the global epidemic of obesity may be due in part to infection with Ad-36." The research was funded in part by the UW Beers-Murphy Clinical Nutrition Center.
-end-


University of Wisconsin-Madison

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.